The Conversation (0)
MedReleaf Signs Supply Agreement with German Pharmacy Distributor
Mar. 19, 2018 09:47AM PST
Cannabis Investing NewsMedReleaf entered into an agreement to become the largest supplier of medical cannabis products to Cannamedical Pharma GMBH a medical cannabis distributor to pharmacies in Germany.
MedReleaf (TSX:LEAF) entered into an agreement to become a supplier of medical cannabis products to Cannamedical Pharma GMBH a medical cannabis distributor to pharmacies in Germany.
As quoted in the press release:
MedReleaf will provide Cannamedical with monthly exports of five of its premium strain varieties significantly improving the predictability and security of drug delivery to the German market. Sales to Germany will commence promptly upon the expected receipt of MedReleaf’s European Medical Agency Good Manufacturing Practices (“GMP”) certification and export permit from Health Canada in the coming weeks.
“Federally legal markets for cannabis outside Canada are by and large focused on medical applications. This plays to MedReleaf’s core strengths in R&D, innovation, quality control, and pharmaceutical grade standards,” said Neil Closner, President and CEO. “Medical cannabis in Germany has been in short supply and Cannamedical is an ideal partner to bring MedReleaf’s premium cannabis products into Germany as one of Europe’s leading cannabis distributors with shared values on patient-centricity, a proven track record, and a growing network of 1,800 pharmacies.”
Source: www.newswire.ca
